Articles
-
2 weeks ago |
bloomberg.com | Sam Hornblower
Hi, it’s Sam in New York. Earlier this year, I wrote about the FDA’s role in igniting the opioid epidemic. More on why this is back in the news in a moment, but first …Help us improve Bloomberg newsletters: Please take a quick survey to share your thoughts on your sign-up experience and what you’d like to see in the future.
-
1 month ago |
bloomberglinea.com | Sam Hornblower |David Hartley
Bloomberg — Más de una de cada cinco personas a las que se recetan analgésicos de liberación prolongada, como OxyContin, desarrollaron una adicción en el plazo de un año, según un estudio publicado recientemente por mandato de la Administración de Alimentos y Medicamentos de EE.UU. (FDA).
-
1 month ago |
mercurynews.com | Sam Hornblower
By Sam Hornblower, Bloomberg NewsMore than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration. The study, repeatedly delayed by more than a decade and released Monday, revealed a far higher percentage of pain patients addicted to opioids than drugmakers’ sales reps claimed in their marketing materials and representations to physicians.
-
1 month ago |
medicalxpress.com | Sam Hornblower
More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration. The study, repeatedly delayed by more than a decade and released on May 5th, revealed a far higher percentage of pain patients addicted to opioids than drugmakers' sales reps claimed in their marketing materials and representations to physicians.
-
1 month ago |
gazettextra.com | Sam Hornblower
More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration. The study, repeatedly delayed by more than a decade and released Monday, revealed a far higher percentage of pain patients addicted to opioids than drugmakers' sales reps claimed in their marketing materials and representations to physicians. Copyright 2025 Tribune Content Agency.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 932
- Tweets
- 299
- DMs Open
- Yes
Just produced this two-part story on undersea cables for Wall Street Week — Part 1 looks at the U.S.–China tech war, Part 2 dives into how hyperscalers are building the internet’s backbone for AI and cloud.
On tonight's "Wall Street Week," a look at how hyperscalers have taken over the business of undersea cables to support our growing data needs, and the potential risks. Tune in at 6 p.m. ET https://t.co/pxx4gxjVml https://t.co/GJCHVPV7ia
Just produced this two-part feature on undersea cables for Wall Street Week — Part 1 looks at the U.S.–China tech war, Part 2 dives into how hyperscalers are building the internet’s backbone for AI and cloud.
Undersea cables carry 99% of the world's internet traffic, but how do these cables work and are they worth the investment? Google’s first employee of its subsea unit, Jayne Stowell, weighs in on tonight's "Wall Street Week." Watch at 6 p.m. ET https://t.co/j4QkHMMtHV https://t.co/57TEb7j6T0
RT @business: An investigation into the FDA's repeated violations of its own rules to approve addictive drugs—and its ongoing failure to re…
